We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
After your faecal microbiota transplant (FMT) product is on the market, you have ongoing responsibilities to meet regulatory requirements.
You must:
Maintain your FMT’s entry in the Australian Register of Therapeutic Goods (ARTG)
notify us of any changes or variations to your product
pay annual charges
monitor safety
report issues
support post-market surveillance.
We oversee these activities to protect public health and ensure FMT products remain safe and effective in Australia. Understanding your responsibilities helps you stay compliant and maintain high product standards.
You must meet certain obligations to legally supply therapeutic goods in Australia. This section contains guidance and information specific to biologicals. You may also have to meet obligations that apply to all biologicals and all products.